arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

INTENSITY THERAPEUTICS, INC.

INTS

$3.15 ▼ -0.31 (-9.09%) at close

19 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

INTENSITY THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $8.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -26.4% ↘

FCF / Share $-0.86 ↘

Trailing P/E —

Price / Book 1.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

19-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-2.43M

↑ +27.3% —

FCF / Share Free cash flow per share

$-0.86

↓ -20.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
EPS Growth YoY (%)	65.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	82.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	70.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	76.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	63.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-843.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-47.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	65.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.8% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	72.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	67.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-84.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	27.3% Excellent ↑ Excellent Improving Year-over-year change in net income	27.3% Excellent ↑ Excellent Improving Year-over-year change in net income	4.1% Caution ↓ Caution Declining Year-over-year change in net income	27.3% Excellent ↑ Excellent Improving Year-over-year change in net income	27.3% Excellent ↑ Excellent Improving Year-over-year change in net income	27.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.3% Weak ↑ Weak Improving Year-over-year change in net income	-97.6% Weak ↑ Weak Improving Year-over-year change in net income	-24.4% Weak ↑ Weak Improving Year-over-year change in net income	-244.5% Weak ↓ Weak Declining Year-over-year change in net income	-110.0% Weak ↓ Weak Declining Year-over-year change in net income	-31.3% Weak Weak Year-over-year change in net income	-92.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	78.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	58.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-20.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
FCF / Net Income (x)	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	-26.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-97.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-802.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-101.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-74.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	7.7% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	12.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-26.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-110.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-67.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-83.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-26.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	-24.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-25.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-46.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-409%)	-153.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1122%)	—	-109.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-827%)	-165.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1204%)	-86.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-674%)	-47.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-416%)	-24.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-14.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	8.4% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-44%)	10.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-33%)	12.5% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	15.4% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	-5.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-116.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	-129.01x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-9.53M	$-10.24M	$-11.92M	$-7.07M	$-2.22M	$-929.00K	$-2.59M	$-2.78M	$-3.24M	$-7.46M	$-8.56M	$-6.69M	$-135.76K	$-8.56M	$-1.31M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Basic EPS, GAAP (USD)	$-1.11	$-0.96	$-8.23	$-1.50	$-3.25	$-5.50	$-28.29	$-6.25	$-9.00	$-8.50	$-3.00	$-4.25	$-26.25	$-9.75	$-11.00	$-13.00	$-14.25	—	—
Free Cash Flow per Share (USD)	$-0.86	$-0.72	—	$-1.39	—	$-3.28	—	—	—	$-7.96	—	—	—	$-6.61	—	$-7.52	—	—	—
Book Value per Share (USD)	$3.13	$3.93	$4.70	$3.68	$2.09	$0.55	$4.82	$5.01	$9.74	$17.73	$24.00	$29.01	$107.59	$-117.03	$-110.69	$-104.21	$-91.49	—	—
Tangible Book Value per Share (USD)	$3.13	$3.93	$4.70	$3.68	$2.09	$0.55	$4.82	$5.01	$9.74	$17.73	$24.00	$29.01	$107.59	$-117.03	$-110.69	$-104.21	$-91.49	—	—
Basic Weighted Avg Shares (shares)	2.71M	2.53M	—	1.72M	754,725	606,928	—	552,186	548,486	548,379	—	546,425	140,663	136,404	—	136,404	136,404	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$8.98M	$8.66M	$10.56M	$5.91M	$874.00K	$-978.00K	$1.61M	$1.47M	$4.24M	$8.65M	$11.51M	$15.91M	$15.00M	—	$-5.37M	—	—	—	—
Total Equity (USD)	$9.21M	$9.98M	$11.88M	$7.22M	$2.18M	$334.00K	$2.92M	$2.78M	$5.34M	$9.72M	$13.16M	$15.91M	$15.13M	$-15.96M	$-15.10M	$-14.21M	$-12.48M	$-8.68M	$-8.69M

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Dec 31, 2021 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Net Income, GAAP (USD)	$-2.43M	$-2.43M	$-3.05M	$-3.35M	$-3.35M	$-3.35M	$-3.18M	$-4.60M	$-4.60M	$-4.60M	$-3.17M	$-2.33M	$-3.70M	$-1.34M	$-1.51M	$-1.77M	$-1.93M	—	—
Operating Cash Flow (USD)	$-2.34M	$-1.83M	$-2.40M	$-2.39M	—	$-1.99M	$-2.67M	—	—	$-4.37M	$-946.00K	—	—	$-901.00K	$-1.63M	$-1.03M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 19 quarters

INTENSITY THERAPEUTICS, INC.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INTS with peers